Detalles de la búsqueda
1.
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel.
Rheumatology (Oxford)
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490262
2.
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.
Rheumatology (Oxford)
; 2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952183
3.
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Rheumatology (Oxford)
; 60(4): 1588-1592, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097948
4.
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial.
Ann Rheum Dis
; 77(1): 55-62, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993346
5.
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC.
Rheumatology (Oxford)
; 62(1): e1-e3, 2022 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35799375
6.
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs.
Rheumatology (Oxford)
; 61(9): 3514-3520, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640653
7.
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs.
Rheumatology (Oxford)
; 61(9): e255-e266, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640657
8.
Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data.
Clin Exp Rheumatol
; 35(5): 810-815, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28516868
9.
Patient involvement in rheumatology outpatient service design and delivery: a case study.
Health Expect
; 20(3): 508-518, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27345769
10.
Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound.
BMC Musculoskelet Disord
; 17(1): 404, 2016 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27659057
11.
Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Arthritis Rheum
; 65(3): 627-38, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23280063
12.
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.
Ther Adv Musculoskelet Dis
; 16: 1759720X241240913, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38826570
13.
Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA.
Rheumatol Adv Pract
; 7(3): rkad055, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37663578
14.
More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease.
Arthritis Res Ther
; 25(1): 108, 2023 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37353811
15.
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
J Rheumatol
; 50(3): 426-432, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319003
16.
FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+CD25- responder T cells, but not CD4+CD25+ regulatory T cells.
J Autoimmun
; 38(1): 29-38, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22197557
17.
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Rheumatology (Oxford)
; 56(12): 2257, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029272
18.
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Rheumatology (Oxford)
; 56(6): 865-868, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28339817
19.
In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses.
Proc Natl Acad Sci U S A
; 106(15): 6232-7, 2009 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19325128
20.
Drug therapy of inflammatory arthritis.
Clin Med (Lond)
; 12(4): 357-63, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22930883